Results
2
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
2 companies
Tibet Rhodiola Pharmaceutical Holding
Market Cap: CN¥15.1b
Tibet Rhodiola Pharmaceutical Holding Co.
600211
CN¥49.79
7D
11.1%
1Y
47.9%
APT Medical
Market Cap: CN¥43.1b
Engages in the research, development, manufacturing, and supply of electrophysiology and vascular interventional medical devices in China.
688617
CN¥315.42
7D
12.6%
1Y
28.1%